Chandra Bhagat Pharma Limited (BOM:542934)
36.00
-0.63 (-1.72%)
At close: Jul 14, 2026
Chandra Bhagat Pharma Revenue
In the fiscal year ending March 31, 2026, Chandra Bhagat Pharma had annual revenue of 1.16B INR with 30.99% growth. Chandra Bhagat Pharma had revenue of 907.26M in the half year ending March 31, 2026, a decrease of -12.12%.
Revenue
1.16B
Revenue Growth
+30.99%
P/S Ratio
0.23
Revenue / Employee
29.07M
Employees
40
Market Cap
271.62M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.16B | 275.05M | 30.99% |
| Mar 31, 2025 | 887.67M | -1.34B | -60.11% |
| Mar 31, 2024 | 2.23B | 1.03B | 85.93% |
| Mar 31, 2023 | 1.20B | 255.97M | 27.21% |
| Mar 31, 2022 | 940.76M | 233.79M | 33.07% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.74B |
| Dipna Pharmachem | 1.29B |
| Medico Intercontinental | 853.55M |
| Medistep Healthcare | 708.31M |
| Constronics Infra | 486.14M |
| Zenlabs Ethica | 469.23M |
| Goldline Pharmaceutical | 311.99M |
| Muller & Phipps (India) | 69.08M |